
Elevance Health, Inc. guidance
$446.28+3.86%Close 16 Nov 2026 · Market value $94.62B
In its results release of 21 Oct 2026 (Q3 FY2026), Elevance Health, Inc. gave 3 forecasts in figures, among them EPS of at least $22.00 for FY2026.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 21 Oct 2026
| Measure | Period | Guidance | As stated |
|---|
| EPS · Reaffirmed | FY2026 | At least $22.00 | During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year 2026 to be at least $22.00 per diluted share, including approximately $7.00 per diluted share of net unfavorable items |
|---|
| EPS · Adjusted · Raised | FY2026 | At least $29.00 | FY 2026 diluted EPS 1 guidance raised to at least $22.00; adjusted diluted EPS 2 guidance raised to at least $29.00 on continued operating momentum |
|---|
| Operating cash flow · Raised | FY2026 | At least $6.50B | FY 2026 operating cash flow guidance raised to at least $6.5 billion |
|---|
Source: the company's earnings release.
Guidance against results above 1 · within 0 · below 1
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| EPS · GAAP | FY2026 | At least $22.30 | Given once | — | To come |
|---|
| EPS · Adjusted | FY2026 | At least $29.00 | Raised twice | — | To come |
|---|
| EPS | FY2026 | At least $22.00 | Raised twice | — | To come |
|---|
| Operating cash flow | FY2026 | At least $6.50B | Raised twice | — | To come |
|---|
| Tax rate · Adjusted | FY2026 | 22% to 24% | Given once | — | To come |
|---|
| EPS · GAAP | FY2025 | About $24.10 | Lowered once | $25.21 | Above the range |
|---|
| EPS · GAAP | FY2024 | About $26.50 | Given once | $25.68 | Below the range |
|---|
ELV in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.